Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gaudard

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Critical Care (London, England)|October 11, 2015
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shockPhilippe Gaudard, Marc Mourad, Jacob Eliet, et al.
BMC Infectious Diseases|May 22, 2019
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysisPhilippe Gaudard, Marine Saour, David Morquin, et al.
Frontiers in Cardiovascular Medicine|April 22, 2024
Inhaled NO at a crossroads in cardiac surgery: current need to improve mechanistic understanding, clinical trial design and scientific evidenceStefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Heart graft preservation technics and limits: an update and perspectivesAurore Ughetto, François Roubille, Adrien Molina, et al.
The Lancet Regional Health. Europe|July 18, 2024
Impact of a bundle of care (intravenous iron, erythropoietin and transfusion metabolic adjustment) on post-operative transfusion incidence in cardiac surgery: a single-centre, randomised, open-label, parallel-group controlled pilot trialMarine Saour, Cinderella Blin, Norddine Zeroual, et al.
Pharmacological Research|September 3, 2016
Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profilePascal H Colson, Anne Virsolvy, Philippe Gaudard, et al.
International Journal of Molecular Sciences|January 21, 2023
Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in RatsPhilippe Gaudard, Hélène David, Patrice Bideaux, et al.
Anesthesiology|January 21, 2021
Restrictive Transfusion Strategy after Cardiac SurgeryNorddine Zeroual, Cinderella Blin, Marine Saour, et al.
Frontiers in Cardiovascular Medicine|February 15, 2021
Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the BrainHélène David, Aurore Ughetto, Philippe Gaudard, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 15, 2017
Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial InfarctionMarc Mourad, Philippe Gaudard, Pablo De La Arena, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Critical Care (London, England)|October 11, 2015
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shockPhilippe Gaudard, Marc Mourad, Jacob Eliet, et al.
BMC Infectious Diseases|May 22, 2019
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysisPhilippe Gaudard, Marine Saour, David Morquin, et al.
Frontiers in Cardiovascular Medicine|April 22, 2024
Inhaled NO at a crossroads in cardiac surgery: current need to improve mechanistic understanding, clinical trial design and scientific evidenceStefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Heart graft preservation technics and limits: an update and perspectivesAurore Ughetto, François Roubille, Adrien Molina, et al.
The Lancet Regional Health. Europe|July 18, 2024
Impact of a bundle of care (intravenous iron, erythropoietin and transfusion metabolic adjustment) on post-operative transfusion incidence in cardiac surgery: a single-centre, randomised, open-label, parallel-group controlled pilot trialMarine Saour, Cinderella Blin, Norddine Zeroual, et al.
Pharmacological Research|September 3, 2016
Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profilePascal H Colson, Anne Virsolvy, Philippe Gaudard, et al.
International Journal of Molecular Sciences|January 21, 2023
Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in RatsPhilippe Gaudard, Hélène David, Patrice Bideaux, et al.
Anesthesiology|January 21, 2021
Restrictive Transfusion Strategy after Cardiac SurgeryNorddine Zeroual, Cinderella Blin, Marine Saour, et al.
Frontiers in Cardiovascular Medicine|February 15, 2021
Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the BrainHélène David, Aurore Ughetto, Philippe Gaudard, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 15, 2017
Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial InfarctionMarc Mourad, Philippe Gaudard, Pablo De La Arena, et al.
Pageof 7